An AI system developed to predict a patient's response to immunotherapy could help "democratize" access to the pricey drugs ...

Eligibility for treatment with the latest cancer drugs is often determined by genetic mutations in tumors, criteria that leave minority patients at a disadvantage due to their under-representation in ...

Oryzon has been invited to participate at the 8th Sachs Annual Neuroscience Innovation Forum, which will be held on January 12 at the Marines’ Memorial Club in San Francisco (USA). The company will ...

Greater transparency, monitoring, and regulatory oversight are needed around these transactions, a researcher says.

A new study found that fewer African and Asian patients had clinically actionable alterations for lung, breast, and colorectal cancer.

A University of Oklahoma professor and his team have discovered a new way to put atoms into drug molecules that could ...

Nearly half of all new cancer drugs approved by the U.S. Food and Drug Administration (FDA) over the past quarter-century ...

During the 66th American Society of Hematology Annual Meeting and Exposition, investigators revealed early-phase 1 data evaluating various BTK degraders that leverage different strategies to overcome ...

Research suggests the benefits of testosterone therapy after prostate cancer surgery in select men may outweigh risks.

U.S. Surgeon General Vivek Murthy issued a new report on alcohol and cancer, which emphasizes the risk of cancer in ...

Artificial intelligence (AI) is pushing the boundaries in therapeutic medicine. AI is the general term that refers to machine ...

Researchers at Mount Sinai and Memorial Sloan Kettering believe they’ve made a breakthrough in a new form of cancer treatment ...